Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESPAC-4: Combination versus single-agent adjuvant chemotherapy in resectable pancreatic ductal and peri-ampullary cancers
2007-004299-38Phase 3Unknown
- Sponsor
- University of Liverpool
- Start
- Dec 2007
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in pancreatic adenocarcinoma (PDAC) and Periampullary Carcinoma comparing Gemcitabine monotherapy with Gemcitabine + capecitabine combination (2 arms). Status: unknown.
02
Drugs
gemcitabinecapecitabine
03
Conditions
pancreatic adenocarcinoma (PDAC)Periampullary Carcinoma
Beyond the preview
Go deeper on 2007-004299-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004299-38.